Company
CV Therapeutics
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Molecular cardiology and drug discovery (acq. by Gilead Sciences)
About the company
- Status notes
- Molecular cardiology and drug discovery (acq. by Gilead Sciences)
Loading relationship preview